STOCK-BASED COMPENSATION (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Expense Related to All of Our Stock-based Awards |
Total stock-based compensation expense related to all of our stock-based awards was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2025 |
|
2024 |
|
2023 |
| Selling, general and administrative |
$ |
10,592 |
|
|
$ |
10,879 |
|
|
$ |
6,712 |
|
| Research and development |
2,119 |
|
|
1,514 |
|
|
2,094 |
|
| Total stock-based compensation expense |
$ |
12,711 |
|
|
$ |
12,393 |
|
|
$ |
8,806 |
|
|
| Schedule of Stock Options and RSUs Activity, and Shares Available For Grant Under Our Equity Incentive Plans |
The following table summarizes stock options and RSUs activity, and shares available for grant under our Equity Incentive Plans for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options |
|
RSUs |
|
Shares Available
For Grant |
|
Number of
Shares |
|
Weighted
Average
Exercise Price |
|
Weighted
Intrinsic Value
(in thousands) |
|
Number of
Shares |
|
Weighted Average
Grant Date
Fair Value |
| Outstanding as of December 31, 2024 |
1,598,221 |
|
3,564,718 |
|
$ |
23.00 |
|
|
|
|
387,282 |
|
$ |
14.94 |
|
| Authorized for grant |
852,868 |
|
|
|
|
|
|
|
|
|
|
| Granted |
(1,215,816) |
|
674,555 |
|
$ |
22.18 |
|
|
|
|
389,522 |
|
$ |
23.14 |
|
| Exercised/Released |
— |
|
(466,591) |
|
$ |
20.61 |
|
|
|
|
(143,691) |
|
$ |
14.92 |
|
| Cancelled and forfeited |
198,789 |
|
(219,248) |
|
$ |
25.69 |
|
|
|
|
(25,492) |
|
$ |
17.36 |
|
| Outstanding as of December 31, 2025 |
1,434,062 |
|
3,553,434 |
|
$ |
23.00 |
|
|
$ |
70,857 |
|
|
607,621 |
|
$ |
20.10 |
|
| Vested and expected to vest as of December 31, 2025 |
|
|
3,384,870 |
|
$ |
22.82 |
|
|
$ |
70,052 |
|
|
|
|
|
| Exercisable as of December 31, 2025 |
|
|
2,764,752 |
|
$ |
23.80 |
|
|
$ |
52,981 |
|
|
|
|
|
|
| Schedule of Weighted-Average Assumptions Relating to Options Granted |
The following table summarizes the weighted-average assumptions relating to stock options granted during the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2025 |
|
2024 |
|
2023 |
| Risk-free interest rate |
4.3 |
% |
|
4.1 |
% |
|
3.9 |
% |
| Expected term (in years) |
6.4 |
|
6.1 |
|
6.8 |
| Dividend yield |
0.0 |
% |
|
0.0 |
% |
|
0.0 |
% |
| Expected volatility |
88.7 |
% |
|
87.7 |
% |
|
84.0 |
% |
|
| Schedule of Stock Options by Exercise Price |
Outstanding stock options and stock options exercisable information by range of exercises prices as of December 31, 2025 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
Options Exercisable |
| Exercise Price |
|
Number of
Shares |
|
Weighted-Average
Remaining Contractual
Life (in years) |
|
Weighted-Average
Exercise Price |
|
Number of
Shares |
|
Weighted-Average
Exercise Price |
$9.0 - $18.7 |
|
1,120,034 |
|
7.59 |
|
$ |
13.82 |
|
|
813,399 |
|
$ |
13.82 |
|
$19.6 - $21.1 |
|
440,680 |
|
3.12 |
|
$ |
20.28 |
|
|
412,356 |
|
$ |
20.36 |
|
$21.4 - $24.0 |
|
607,484 |
|
8.21 |
|
$ |
22.65 |
|
|
276,122 |
|
$ |
22.83 |
|
$24.2 - $24.2 |
|
500,575 |
|
4.73 |
|
$ |
24.20 |
|
|
471,324 |
|
$ |
24.20 |
|
$24.4 - $35.4 |
|
522,208 |
|
4.30 |
|
$ |
31.56 |
|
|
429,098 |
|
$ |
31.51 |
|
$35.9 - $39.80 |
|
180,307 |
|
3.65 |
|
$ |
37.51 |
|
|
180,307 |
|
$ |
37.51 |
|
$40.7 - $45.0 |
|
182,146 |
|
2.07 |
|
$ |
44.90 |
|
|
182,146 |
|
$ |
44.90 |
|
$9.0 - $45.0 |
|
3,553,434 |
|
5.77 |
|
$ |
23.00 |
|
|
2,764,752 |
|
$ |
23.80 |
|
|